Offshoring Vs. Nearshoring, API Manufacturing Sourcing Decisions

The decision to offshore or nearshore API sourcing in the pharmaceutical industry is not only about managing costs but also about ensuring a stable and reliable supply of lifesaving medications.

Over 60% of APIs used in the United States are sourced from just two countries—India and China—with India alone accounting for 48% and China 13%.

In this article, Ash Gude shares key considerations for weighing the benefits of offshoring and nearshoring in the pharmaceutical industry. Nearshoring helps manufacturers make strategic decisions that balance cost-efficiency with the need for a stable, responsive, and compliant supply chain, ensuring the consistent availability of high-quality APIs:

Reducing Total Cost of Ownership (TCO)
Speed and Time-to-Market
Inventory Optimization
Regulatory Compliance
Customer Proximity and Satisfaction

He also talks about why while there are clear benefits to both offshoring and nearshoring API sourcing, companies must also carefully consider the associated risks:

Political Risks
Economic Risks
Freight and Logistics Risks
Technological Risks

The decision to offshore or nearshore API sourcing involves balancing cost, quality, and supply chain risks. Offshoring can reduce costs but adds risks like supply disruptions and regulatory challenges, while nearshoring offers more control but higher costs. The choice depends on a company’s strategy, regulatory needs, and risk tolerance. A well-informed, risk-based approach is key to ensuring a reliable supply of medications and long-term success in the pharmaceutical industry.

Frequently Asked Questions

Why do API sourcing decisions require a more nuanced approach than simple cost comparison?

API sourcing decisions require a nuanced approach because lowest cost does not equal lowest risk. The article explains that offshoring and nearshoring choices affect lead times, supply reliability, quality consistency, and responsiveness to demand changes. When manufacturers evaluate API sourcing solely on price, they often underestimate execution risk and downstream operational impact that can erode margins and disrupt supply continuity.

What risks should manufacturers consider when offshoring or nearshoring API production?

The article highlights risks such as supply chain disruption, regulatory complexity, quality variation, and limited visibility into supplier execution capability. Long lead times and geographic distance can slow problem resolution and amplify variability. Without strong operational discipline and supplier alignment, these risks can outweigh the apparent cost advantages of offshore sourcing.

How can manufacturers make more informed API sourcing decisions?

Manufacturers can make better sourcing decisions by evaluating total cost, execution capability, and resilience alongside price. The article emphasizes assessing supplier reliability, process stability, regulatory readiness, and responsiveness. When sourcing decisions are grounded in operational reality and supported by disciplined management systems, manufacturers can balance cost, risk, and flexibility—creating more sustainable API supply strategies over the long term.